Wolf-michael Weber

Muenster, NW 48149, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Restoration of Defective CFTR in Human Nasal Respiratory Epithelial Cells by CFTR Modulators and mRNA Transfection.

Restoration of Defective CFTR in Human Nasal Respiratory Epithelial Cells by CFTR Modulators and mRNA Transfection.

Journal: International journal of molecular sciences

Published: January 12, 2026

Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study.

Assessing CFTR Function and Epithelial Morphology in Human Nasal Respiratory Cell Cultures: A Combined Immunofluorescence and Electrophysiological Study.

Journal: International journal of molecular sciences

Published: July 02, 2025

Capsaicin-Loaded Chitosan Nanocapsules for wtCFTR-mRNA Delivery to a Cystic Fibrosis Cell Line.

Capsaicin-Loaded Chitosan Nanocapsules for wtCFTR-mRNA Delivery to a Cystic Fibrosis Cell Line.

Journal: Biomedicines

Published: August 12, 2020

Chitosan Nanocomplexes for the Delivery of ENaC Antisense Oligonucleotides to Airway Epithelial Cells.

Chitosan Nanocomplexes for the Delivery of ENaC Antisense Oligonucleotides to Airway Epithelial Cells.

Journal: Biomolecules

Published: March 03, 2020

Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.

Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.

Journal: PloS one

Published: June 13, 2016

Chitosan as a non-viral co-transfection system in a cystic fibrosis cell line.

Chitosan as a non-viral co-transfection system in a cystic fibrosis cell line.

Journal: International journal of pharmaceutics

Published: November 18, 2015

Targeting ENaC as a Molecular Suspect in Cystic Fibrosis.

Targeting ENaC as a Molecular Suspect in Cystic Fibrosis.

Journal: Current drug targets

Published: November 04, 2014

Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.

Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.

Journal: The journal of gene medicine

Published: February 28, 2013

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis.

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis.

Journal: Molecular therapy. Nucleic acids

Published: January 17, 2013

Sildenafil acts as potentiator and corrector of CFTR but might be not suitable for the treatment of CF lung disease.

Sildenafil acts as potentiator and corrector of CFTR but might be not suitable for the treatment of CF lung disease.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: March 03, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026